Kristen
Showing 1–2 of 2 transcripts.
- Milken Institute58 min
New Horizons for Accelerating Drug Repurposing
Dr. David Fajgenbaum, Ray, Kristen, Marianne Clancy, Christine Colvis
Hosted by TRiN and Faster Cures, this webinar featured experts from EveryCure, CURE HHT, and NCATS to examine strategies for accelerating the repurposing of existing drugs for rare diseases. Presenters detailed how AI-driven knowledge graphs and patient-led advocacy successfully navigated financial, intellectual property, and regulatory hurdles to secure approvals for conditions like Castleman's disease and Hereditary Hemorrhagic Telangiectasia. The session concluded with a consensus that generating clinical evidence and securing payment pathways are more critical than intellectual property protection for bringing generic therapies to new indications.
- Milken Institute1h 8m
How to Accelerate Gender Diversity on Boards
Celia Huber, Denise Morrison, Ronald O'Hanley, NV Tyagarajan, Rich Dottizio, Ron O'Hanley, SHARMINI PERIES, Kristen, Hope Tates, Amy Wilkinson, Nan Morris, Anna Chapman, Kelly Close, John Stackhouse
At the Milken Institute's 20th Annual Global Conference, CEOs from State Street Global Advisors, Campbell Soup, and Genpak argued that gender-diverse boards are essential for solving complex problems and driving shareholder value. These leaders identified systemic barriers such as conservative search firm practices and risk aversion while outlining actionable strategies like expanding recruitment criteria and implementing rigorous diversity metrics. The event concluded with a consensus that deliberate change requires CEO accountability and institutional leverage to achieve the industry's "30% Club" target.